WithdrawnPhase 4NCT02400775

A Study to Evaluate the Effects of Azilsartan on Coronary Artery Plaque in Essential Hypertensive Patients With Stable Angina and Dyslipidemia.

Studying Disorder of lipid metabolism

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Takeda
Principal Investigator
General Manager
Takeda
Intervention
Azilsartan(drug)
Eligibility
20 years · All sexes
Timeline
20152016

Study locations (1)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT02400775 on ClinicalTrials.gov

Other trials for Disorder of lipid metabolism

Additional recruiting or active studies for the same condition.

See all trials for Disorder of lipid metabolism

← Back to all trials